Confluent Medical Technologies

Confluent Medical Technologies

Confluent Medical Technologies was established in 2004 through the merger of several specialty medical tubing and catheter firms, operating as a portfolio company of the private equity firm GTCR. The company is headquartered in Scottsdale, Arizona, and designs, develops, and manufactures minimally invasive medical devices and components. Its wealth origins trace to GTCR's buyout and subsequent bolting together of legacy businesses such as Putnam Plastics and MicroLumen. Strategy focuses on three product lines: catheter systems and shaft construction, metal implants and delivery systems (including braided and laser-cut stents), and composite tubing assemblies. The firm works with both Fortune 500 medical-device OEMs and smaller innovators, covering roughly 80% of the top 30 global device makers as customers. Its geographic footprint includes facilities in the US, Ireland, and Costa Rica. The firm employs an estimated 3,000 people across multiple manufacturing sites. In 2024, GTCR sold a majority stake in Confluent to the private equity firm Leonard Green & Partners, with GTCR retaining a minority position. The transaction valued the company at approximately $3.6 billion. Confluent maintains no public AUM data, as it is an operating company, not an investment vehicle. Confluent's structural differentiator lies in its full vertical integration from raw material (polymers, metals) to finished sterile product. This contrasts with medical-device supply chains that typically fragment design, tubing, braiding, and final assembly across separate owners — a model that allows Confluent to compress development cycles and control quality across the production loop.